2021
DOI: 10.1016/j.eplepsyres.2021.106549
|View full text |Cite
|
Sign up to set email alerts
|

Spike-Wave Index Assessment and Electro-Clinical Correlation in Patients with Encephalopathy Associated with Epileptic State During Slow Sleep (ESES / CSWS); Single-Center Experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
21
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(22 citation statements)
references
References 40 publications
0
21
1
Order By: Relevance
“…According to the results of the survival analysis, although the probability of ESES resolution of children diagnosed with ESES at ≥ 7.3 years of age was higher than that of children diagnosed with ESES at < 7.3 years of age after PER add-on treatment (73.8% vs. 34.6%, p = 0.008), no statistically significant difference in the therapeutic effect was found (64.3% vs. 43.6%, p = 0.166) when the patients were grouped according to the age of add-on PER initiation (≥9.8 years vs. < 9.8 years), indicating that an earlier age at disease onset corresponds to a worse response to the drug, but not due to older children are more likely to have selflimited ESES. Unlike previous studies (Öztoprak et al, 2021;van den Munckhof et al, 2015), MRI abnormalities did not lead to differences in the treatment results, which may be related to the milder MRI changes in our enrolled children. Cox multivariate regression results showed that an ESES duration > 2 years before add-on PER initiation was a risk factor for treatment failure, which is also consistent with previous reports demonstrating that prolonged discharge affects synaptic plasticity and causes abnormal neural circuit formation, which indicates that ESES may require more aggressive treatment.…”
Section: Discussioncontrasting
confidence: 78%
“…According to the results of the survival analysis, although the probability of ESES resolution of children diagnosed with ESES at ≥ 7.3 years of age was higher than that of children diagnosed with ESES at < 7.3 years of age after PER add-on treatment (73.8% vs. 34.6%, p = 0.008), no statistically significant difference in the therapeutic effect was found (64.3% vs. 43.6%, p = 0.166) when the patients were grouped according to the age of add-on PER initiation (≥9.8 years vs. < 9.8 years), indicating that an earlier age at disease onset corresponds to a worse response to the drug, but not due to older children are more likely to have selflimited ESES. Unlike previous studies (Öztoprak et al, 2021;van den Munckhof et al, 2015), MRI abnormalities did not lead to differences in the treatment results, which may be related to the milder MRI changes in our enrolled children. Cox multivariate regression results showed that an ESES duration > 2 years before add-on PER initiation was a risk factor for treatment failure, which is also consistent with previous reports demonstrating that prolonged discharge affects synaptic plasticity and causes abnormal neural circuit formation, which indicates that ESES may require more aggressive treatment.…”
Section: Discussioncontrasting
confidence: 78%
“…Exclusion criteria: (1) complicated with an epileptic syndrome (e.g., Lennox-Gastaut syndrome, West syndrome), [11][12][13] (2) complicated with other serious diseases (e.g., severe hepatic or renal insufficiency, severe heart failure), and (3) patients who could not follow standard treatment or treatment protocols used by the authors.…”
Section: Methodsmentioning
confidence: 99%
“…The EEG outcomes were : Effective, the ESES mode disappeared or the SWI improved by ≤50%; ineffective, the SWI improved by <50%. We used the following formula to calculate the total effectiveness EEG rate 11 :Total0.25emEEG0.25emeffectiveness rategoodbreak=the number of children with effective0.25emEEG0.25emoutcometotal number of childrengoodbreak×100…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Studies on SWI in the 50–85% range are still lacking, and its clinical significance has not been clearly defined. However, recent studies demonstrated that even RE patients with SWI between 50 and 85% suffered from failure of monotherapy and a poor long-term prognosis of cognitive function ( Oztoprak et al, 2021 ; Ucar et al, 2022 ). Recently, it has been noted that RE patients with SWI ≥ 50% perform significantly worse on arithmetic calculations, executive functions, attention and memory tests than children with SWI < 50% ( Zhang J. et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%